Evidence map›Paper›PMID 39220916›Full record

ReviewHeliyon2024

A holistic review on red fluorescent graphene quantum dots, its synthesis, unique properties with emphasis on biomedical applications.

Shanmuga Priya Mohanaraman, Ramalingam Chidambaram

Abstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Graphene-Oxide Peptide-Containing Materials for Biomedical Applications.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shanmuga Priya MohanaramanInstrumental and Food Analysis Laboratory, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Ramalingam ChidambaramInstrumental and Food Analysis Laboratory, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene quantum dots (GQDs) are an evolving class of carbon-based nanomaterial, seizing tremendous attention owing to their intense optical property, engineered shapes and structures, and good photostability. Being a zero-dimensional form of carbon structure, GQDs have superior photoluminescent behavior, tunable emission and absorption, excellent biocompatibility, low cytotoxicity, hydrophilic nature, modifying surface states. Their water dispersibility and functionalized surface structure, involving heteroatoms and various functional groups onto the surface of GQDs, make them particularly suitable for biological applications. Based on their absolute luminescence properties, GQDs emit blue, green, yellow, and red light under ultraviolet irradiation. Amongst the three colors, red luminescence can achieve deeper penetration of light into tissues, good cellular distribution, bio-sensing property, cell imaging, drug delivery, and serves as a better candidate for photodynamic therapy. The overall objective of this review is to provide a comprehensive overview of the synthesis methods for red fluorescence graphene quantum dots (RF-GQDs), critical comparative analyses of spectral techniques used for their characterization, the tunable photoluminescence mechanisms underpinning red emission, and the significance of chemically functionalizing GQDs' surface edges in achieving red fluorescence are discussed in depth. This review also discusses the effective biological applications and critical challenges associated with RF-GQDs are examined, providing insights into their future potential in clinical and industrial applications.

Indexed as

BiocompatibilityBiomedical applicationGraphene quantum dotsLuminescenceRed fluorescence graphene quantum dots

Identifiers

PMID39220916
PMCPMC11365325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.